A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Lydia Bellmann, Giuseppe Cappellano, Johanna F. Schachtl‐Riess, Anastasia Prokopi, Athanasios Seretis, Daniela Ortner, Christoph H. Tripp, Constance E. Brinckerhoff, David W. Mullins, Patrizia Stoitzner

Journal title: International Journal of Cancer

Journal number: 146/5

Journal publisher: John Wiley & Sons Inc.

Published year: 2019

Published pages: 1409-1420

DOI identifier: 10.1002/ijc.32777

ISSN: 0020-7136